Overview
- ALS-Hilfe Bayern will receive Fernsehlotterie financing for two half-time counseling posts for three years starting in October to professionalize support for patients and families.
- Families describe frequent stigmatizing encounters in public spaces, with caregivers recounting exclusion and misunderstanding during routine outings.
- Patients report protracted battles with health insurers to obtain wheelchairs, hospital beds and lifts, with approvals often delayed until needs become acute.
- ALS is a rare, fatal motor-neuron disease affecting roughly 1–2 people per 100,000 annually, with early signs such as fasciculations, cramps, limb weakness, gait instability and speech or swallowing difficulties.
- There is no cure; Riluzol may slow progression and multidisciplinary therapies and assistive devices remain central, while a University of Bielefeld team reports an AI gene-based predictor with about 87% stated accuracy.